Search results
Found 6147 matches for
The University of Oxford, in collaboration with AstraZeneca plc, today announces interim trial data from its Phase III trials that show its candidate vaccine, ChAdOx1 nCoV-2019, is effective at preventing COVID-19 (SARS-CoV-2) and offers a high level of protection.
Sir Andrew Pollard
Researchers and Research Support M-Z
BSc MBBS PhD (Lond), DIC, MRCP (UK), FHEA, FRCPCH, MA, FMedSci, FRS Sir Andrew Pollard - Ashall Professor of Infection & Immunity
Amber Thompson
Researchers and Research Support M-Z
Amber Thompson - Senior QA and Sample Compliance Manager
Sarah Atkinson
Researchers and Research Support A-L
MBBS, BSc, MRCPCH, DTM&H, PhD, PGDipPID Sarah Atkinson - Associate Professor and Honorary Consultant in Paediatrics and Paediatric Infectious Disease
Rashid Mwadzame
Researchers and Research Support M-Z
Rashid Mwadzame - Clinical Research Practitioner
Freya Stiff
Researchers and Research Support M-Z
Freya Stiff - Post-Graduate Laboratory Research Assistant
Jennifer Cane
Researchers and Research Support A-L
Jennifer Cane - Senior Research Scientist in Outbreak Pathogens
Simon Drysdale
Researchers and Research Support A-L
Simon Drysdale - Senior Vaccine Clinical Trials Pediatrician
Daniel O'Connor
Researchers and Research Support M-Z
BSc AFHEA MSc DPhil (OXON) Daniel O'Connor - Associate Professor | Head of Bioinformatics
Siddhesh Vishwakarma
Researchers and Research Support M-Z
Siddhesh Vishwakarma - Laboratory Research Assistant
James Pitchfork
Researchers and Research Support M-Z
James Pitchfork - Apprentice Clinical Trial Laboratory Technician
Sthefany Pagliari
Researchers and Research Support M-Z
Sthefany Pagliari - Postdoctoral Research Scientist